Evidence map›Paper›PMID 38287329›Full record

ArticleSubstance abuse treatment, prevention, and policy2024

Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators.

Megan A O'Grady, Katherine S Elkington, Gail Robson, Ikenna Y Achebe, Arthur Robin Williams, Alwyn T Cohall, Renee Cohall, Monica Christofferson, Alejandra Garcia, Kelly S Ramsey and 2 more

Open access · goldAbstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Megan A O'GradyDepartment of Public Health Sciences, University of Connecticut School of Medicine, 263 Farmington Ave, Farmington, CT, 06030, USA. ogrady@uchc.edu.
Katherine S ElkingtonHIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University, New York, NY, USA.
Gail RobsonCallen-Lorde Community Health Center, New York, NY, USA.
Ikenna Y AchebeCenter for Behavioral Health and Youth Justice, Columbia University, New York Psychiatric Institute, New York, NY, USA.
Arthur Robin WilliamsDivision on Substance Use Disorders, New York State Psychiatric Institute, New York, NY, USA.
Alwyn T CohallDepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.
Renee CohallDepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.
Monica ChristoffersonCenter for Justice Innovation, New York, NY, USA.
Alejandra GarciaCenter for Justice Innovation, New York, NY, USA.
Kelly S RamseyNew York State Office of Addiction Services and Supports, Albany, NY, USA.
Pat LincourtNew York State Office of Addiction Services and Supports, Albany, NY, USA.
Susan TrossHIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University, New York, NY, USA.
Columbia University · USInternational Center for Transitional Justice · USCommunity Health Center · USNew York State Psychiatric InstituteUniversity of Connecticut · US

Funding

Leveraging Social Networks to Increase COVID-19 Testing Uptake: A Comparison of Credible Messenger and Chain Referral Recruitment ApproachesUG1DA050071 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ELKINGTON, KATHERINE S, NUNES, EDWARD V. · 2019 to 2023
$9.5M
NIDA NIH HHS UG1 DA050071NIH HHS 5UG1DA050071
6 · The paper itself

Abstract

backgroundPeople with opioid use disorder (OUD) are frequently in contact with the court system and have markedly higher rates of fatal opioid overdose. Opioid intervention courts (OIC) were developed to address increasing rates of opioid overdose among court defendants by engaging court staff in identification of treatment need and referral for opioid-related services and building collaborations between the court and OUD treatment systems. The study goal was to understand implementation barriers and facilitators in referring and engaging OIC clients in OUD treatment.

methodsSemi-structured interviews were conducted with OIC stakeholders (n = 46) in 10 New York counties in the United States, including court coordinators, court case managers, and substance use disorder treatment clinic counselors, administrators, and peers. Interviews were recorded and transcribed and thematic analysis was conducted, guided by the Exploration, Preparation, Implementation, Sustainment (EPIS) framework, employing both inductive and deductive coding.

resultsResults were conceptualized using EPIS inner (i.e., courts) and outer (i.e., OUD treatment providers) implementation contexts and bridging factors that impacted referral and engagement to OUD treatment from the OIC. Inner factors that facilitated OIC implementation included OIC philosophy (e.g., non-punitive, access-oriented), court organizational structure (e.g., strong court staff connectedness), and OIC court staff and client characteristics (e.g., positive medications for OUD [MOUD] attitudes). The latter two also served as barriers (e.g., lack of formalized procedures; stigma toward MOUD). Two outer context entities impacted OIC implementation as both barriers and facilitators: substance use disorder treatment programs (e.g., attitudes toward the OIC and MOUD; operational characteristics) and community environments (e.g., attitudes toward the opioid epidemic). The COVID-19 pandemic and bail reform were macro-outer context factors that negatively impacted OIC implementation. Facilitating bridging factors included staffing practices that bridged court and treatment systems (e.g., peers); barriers included communication and cultural differences between systems (e.g., differing expectations about OIC client success).

conclusionsThis study identified key barriers and facilitators that OICs may consider as this model expands in the United States. Referral to and engagement in OUD treatment within the OIC context requires ongoing efforts to bridge the treatment and court systems, and reduce stigma around MOUD.

Indexed as

BuprenorphineOpiate OverdoseOpioid-Related DisordersAnalgesics, OpioidHumansNew YorkOpiate Substitution TreatmentPandemicsAnalgesics, OpioidBuprenorphineCourtsCriminal justiceMedications for opioid use disorderOpioid intervention courtOpioid overdoseOpioid use disorderSubstance use disorder treatment

Identifiers

PMID38287329
PMCPMC10826099
OpenAlexW4391300691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.